Showing 2161-2170 of 8915 results for "".
Show and tell – infographic marketing tips for dermatologists
https://practicaldermatology.com/topics/practice-management/show-and-tell-infographic-marketing-tips-for-dermatologists/19693/Do you struggle to communicate research studies, statistics, aftercare instructions, and other complex ideas to your patients? This Ekwa Marketing video shows you how to simplify data and give it visual appeal with infographics.Things You Must Do to Improve Your Dermatology Website
https://practicaldermatology.com/topics/practice-management/improvewebsite/19552/Your website acts as the digital face of your dermatology practice. While the nitty-gritty of the actual website may vary widely due to a host of factors, there are some basic essentials that no dermatology website can do without. In This Ekwa Marketing video, we discuss four such absolute essentialApproval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by healBespoke for Bros: A Different Approach for Male Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/bespoke-for-bros-a-different-approach-for-male-patients-/19561/Physical features aside, there may be important differences in how male patients think about and approach cosmetic concerns. According to Heidi Waldorf, MD, while women tend to seek a youthful appearance, men often want to appear as though they have not aged—and stopping the aging clock requires a fLift Off: Non-Invasive Skin Tightening
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lift-off-non-invasive-skin-tightening/18223/Arisa Ortiz, MD says that minimally invasive devices won't approach surgical results, but patients can get significant improvement. She discusses patient selection, expectations, and outcomes with host Joel L. Cohen, MD.Medical Derm at Summer AAD; Novel Drugs, Acne at Derm 2018
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-medical-derm-at-summer-aad-novel-drugs-acne-at-derm-2018/18244/The Summer meeting of the American Academy of Dermatology (AAD) gathers members for updates on medical and aesthetic advancements. This year, topics included advanced therapeutics, skin cancer, and skin of color. DERM 2018 provides an opportunity for nurse practitioners and physician assistants in dUV Talk: Spread the Message
https://practicaldermatology.com/topics/skin-cancer-photoprotection/uv-talk-spread-the-message/18696/The public isn't getting the UV protection message. They need to use the right sunscreens with the right ingredients, and use them the right way. Joel L. Cohen, MD explains.Aesthetic A-Peel: Using Peels in Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-a-peel-using-peels-in-practice/18556/As devices continue to evolve so do more "conventional" treatments, like peels. Dr. Gilbert talks about advancements in peels and the rise of nutraceuticals.Improving Patient Interactions
https://practicaldermatology.com/topics/practice-management/improving-patient-interactions/18805/From treating hospitalized patients, to delivering bad news, to helping patients manage chronic conditions, and even dealing with difficult patients, this episode of Derm Insider focuses on improving patient care and the doctor/patient relationship. Joanna L. Harp, MD, Kanade Shinkai, MD, PhD, KristEnstilar Approved; New Data for Otezla, Duac
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enstilar-approved-new-data-for-otezla-duac/18687/LEO Pharma's Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% has been FDA-approved for plaque psoriasis. New data presented at EADV on Stiefel's Duac, Celgene's Otezla, and Boehringer Ingelheim's investigational biologic compound BI 655066. Plus, Galderma's OTC Excipial l